Gencia Corporation

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gencia Corporation.The latest application filed is for "compositions and methods for treating conditions that affect epidermis".

Company Profile

0.13.22

Gencia Corporation - Charlottesville VA US
Gencia Corporation - Charlottsville VA
Gencia Corporation -

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions and Methods for Treating Conditions That Affect Epidermis App 20180000846 - Khan; Shaharyar ; et al.	2018-01-04
Compositions and methods for treating conditions that affect epidermis Grant 9,707,244 - Khan , et al. July 18, 2	2017-07-18
Modified creatine compounds Grant 9,434,753 - Khan , et al. September 6, 2	2016-09-06
Methods of Mitigating Side Effects of Radiation Exposure and Chemotherapy App 20160038565 - Khan; Shaharyar	2016-02-11
Compositions and Methods for Treating Conditions that Affect Epidermis App 20160022709 - Khan; Shaharyar ; et al.	2016-01-28
Compositions and Methods for Enhancing Immune Responses App 20150283233 - Khan; Shaharyar	2015-10-08
Nonviral vectors for delivering polynucleotides to target tissue Grant 8,952,133 - Khan February 10, 2	2015-02-10
Transducible polypeptides for modifying metabolism Grant 8,927,691 - Khan January 6, 2	2015-01-06
Modified Creatine Compounds App 20150005258 - Khan; Shaharyar M. ; et al.	2015-01-01
Synthetic lipid rafts and methods of use Grant 8,906,390 - Khan December 9, 2	2014-12-09
Transducible Polypeptides for Modifying Metabolism App 20140113853 - Khan; Shaharyar	2014-04-24
Mitochondrial Compositions And Uses Thereof App 20140045798 - Khan; Shaharyar	2014-02-13
Transducible Polypeptides For Modifying Metabolism App 20130302876 - Khan; Shaharyar	2013-11-14
Methods and compositions for delivering polynucleotides Grant 8,541,550 - Khan September 24, 2	2013-09-24
Nonviral vectors for delivering polynucleotides Grant 8,507,277 - Khan August 13, 2	2013-08-13
Nonviral vectors for delivering polynucleotides to plants Grant 8,470,972 - Khan June 25, 2	2013-06-25
Mitochondrial Compositions and Uses Thereof App 20130072462 - Khan; Shaharyar	2013-03-21
Transducible Polypeptides For Modifying Metabolism App 20120231521 - Khan; Shaharyar	2012-09-13
Nonviral Vectors For Delivering Polynucleotides To Target Tissue App 20120149097 - Khan; Shaharyar	2012-06-14
Nonviral vectors for delivering polynucleotides to target tissues Grant 8,133,733 - Khan March 13, 2	2012-03-13
Nonviral Vectors For Delivering Polynucleotides To Plants App 20120005776 - KHAN; SHAHARYAR	2012-01-05
Methods And Compositions For Delivering Polynucleotides App 20110300600 - Khan; Shaharyar	2011-12-08
Nonviral vectors for delivering polynucleotides to plants Grant 8,062,891 - Khan November 22, 2	2011-11-22
Methods and compositions for delivering polynucleotides Grant 8,039,587 - Khan October 18, 2	2011-10-18
Mitochondrial Compositions And Uses Thereof App 20100179106 - Khan; Shaharyar	2010-07-15
Nonviral Vectors For Delivering Polynucleotides To Target Tissue App 20090227655 - Khan; Shaharyar	2009-09-10
Transducible Polypeptides For Modifying Metabolism App 20090208478 - Khan; Shaharyar M.	2009-08-20
Transducible Polypeptides For Modifying Metabolism App 20090123468 - Khan; Shaharyar	2009-05-14
Nonviral Vectors For Delivering Polynucleotides To Plants App 20080222750 - Khan; Shaharyar	2008-09-11
Synthetic Lipid Rafts and Methods of Use App 20070275924 - Khan; Shaharyar	2007-11-29
Nonviral vectors for delivering polynucleotides App 20060211647 - Khan; Shaharyar	2006-09-21

Company Registrations

NCAGE Code	46A22	GENCIA CORPORATION
CAGE Code	46A22	GENCIA CORPORATION
DUNS	140452710	Gencia Corporation

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.